ArticleMedical physics2022
DblurDoseNet: A deep residual learning network for voxel radionuclide dosimetry compensating for single-photon emission computerized tomography imaging resolution.
Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Artificial Intelligence Across the Cancer Theranostics Workflow: Critical Appraisal of Current Evidence and Future Clinical Translation.Molecular imaging and biology · 2026Review
- Towards practical radiopharmaceutical treatment planning: a review of dosimetry simplification techniques.Theranostics · 2026Review
- Instrumentation Digital Twins in PET and SPECT Imaging: Current Status, Challenges, and Future Directions.Computational and structural biotechnology journal · 2026Review
- The Role of Artificial Intelligence in Theranostics.Journal of nuclear medicine technology · 2025Review
- The Role of Artificial Intelligence in Advancing Theranostics Dosimetry for Cancer Therapy: a Review.Nuclear medicine and molecular imaging · 2025Review
- Evaluating auto-contouring accuracy in reduced CT dose images for radiopharmaceutical therapies: Denoising and evaluation ofJournal of applied clinical medical physics · 2025Article
- Linear Boltzmann equation solver for voxel-level dosimetry in radiopharmaceutical therapy: Comparison with Monte Carlo and kernel convolution.Medical physics · 2024Article
- Image-based dosimetry for [European journal of nuclear medicine and molecular imaging · 2024Article
- A Deep-Learning-Based Partial-Volume Correction Method for QuantitativeJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [European journal of nuclear medicine and molecular imaging · 2024Article
- Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens.Diagnostics (Basel, Switzerland) · 2024Review
- Theranostics and artificial intelligence: new frontiers in personalized medicine.Theranostics · 2024Review
- 90Y SPECT scatter estimation and voxel dosimetry in radioembolization using a unified deep learning framework.EJNMMI physics · 2023Article
- Physics-Guided Deep Scatter Estimation by Weak Supervision for Quantitative SPECT.IEEE transactions on medical imaging · 2023Article
- A machine learning-based model for a dose point kernel calculation.EJNMMI physics · 2023Article
- Voxel-Based Internal Dosimetry forNuclear medicine and molecular imaging · 2023Article
- A Machine Learning based model for a Dose Point Kernel calculation.Research square · 2023Article
- A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging AfterJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeCurrent methods for patient-specific voxel-level dosimetry in radionuclide therapy suffer from a trade-off between accuracy and computational efficiency. Monte Carlo (MC) radiation transport algorithms are considered the gold standard for voxel-level dosimetry but can be computationally expensive, whereas faster dose voxel kernel (DVK) convolution can be suboptimal in the presence of tissue heterogeneities. Furthermore, the accuracies of both these methods are limited by the spatial resolution of the reconstructed emission image. To overcome these limitations, this paper considers a single deep convolutional neural network (CNN) with residual learning (named DblurDoseNet) that learns to produce dose-rate maps while compensating for the limited resolution of SPECT images.
methodsWe trained our CNN using MC-generated dose-rate maps that directly corresponded to the true activity maps in virtual patient phantoms. Residual learning was applied such that our CNN learned only the difference between the true dose-rate map and DVK dose-rate map with density scaling. Our CNN consists of a 3D depth feature extractor followed by a 2D U-Net, where the input was 11 slices (3.3 cm) of a given Lu-177 SPECT/CT image and density map, and the output was the dose-rate map corresponding to the center slice. The CNN was trained with nine virtual patient phantoms and tested on five different phantoms plus 42 SPECT/CT scans of patients who underwent Lu-177 DOTATATE therapy.
resultsWhen testing on virtual patient phantoms, the lesion/organ mean dose-rate error and the normalized root mean square error (NRMSE) relative to the ground truth of the CNN method was consistently lower than DVK and MC, when applied to SPECT images. Compared to DVK/MC, the average improvement for the CNN in mean dose-rate error was 55%/53% and 66%/56%; and in NRMSE was 18%/17% and 10%/11% for lesion and kidney regions, respectively. Line profiles and dose-volume histograms demonstrated compensation for SPECT resolution effects in the CNN-generated dose-rate maps. The ensemble noise standard deviation, determined from multiple Poisson realizations, was improved by 21%/27% compared to DVK/MC. In patients, potential improvements from CNN dose-rate maps compared to DVK/MC were illustrated qualitatively, due to the absence of ground truth. The trained residual CNN took about 30 s on a single GPU (Tesla V100) to generate a 512
conclusionThe proposed residual CNN, trained using phantoms generated from patient images, has potential for real-time patient-specific dosimetry in clinical treatment planning due to its demonstrated improvement in accuracy, resolution, noise, and speed over the DVK/MC approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.